Assistant Professor in the Division of Pulmonary, Allergy and Critical Care Medicine, Jason J. Rose, M.D., M.B.A., has been appointed as the Associate Vice Chair for Innovation and Commercialization in the Department of Medicine. In this newly created position, Dr. Rose will work closely with Dr. Timothy Billiar (George Vance Foster Professor and Chair, Department of Surgery, Chief Scientific Officer for UPMC) and me to foster innovation and commercialization opportunities for investigators throughout the Department of Medicine in a collaboration with UPMC Enterprises and the University of Pittsburgh.
Dr. Rose completed a BSE in Biomedical Engineering from the University of Michigan in 2006 and went on to attend medical school at Wayne State University. He completed residency in Internal Medicine at Duke University Medical Center in 2013 before coming to the University of Pittsburgh in 2013 for his clinical and research fellowship training in Pulmonary, Allergy and Critical Care Medicine (PACCM). He joined the faculty of PACCM in 2016 as a Clinical Instructor and was promoted to Assistant Professor of Medicine and Bioengineering in 2017. Dr. Rose obtained his MBA from the Tepper School of Business at Carnegie Mellon University in 2017 to pursue his entrepreneurial aspirations for drug development in the field of inhalational toxicology.
His research work in carbon monoxide poisoning contributed to the development of a novel class of antidotal therapies—leading to multiple inventions and a spin-out company, Globin Solutions, Inc., which he co-founded in 2017. Dr. Rose currently serves as the President & CEO of Globin Solution. Under his leadership, Globin Solutions raised Series A funding in 2018 and was awarded a multi-PI Phase I/II Fast-Track STTR grant from the NIH in 2020. In support of his academic pursuits, he received a K08 award from the NIH, a Parker B Francis Fellowship, a Young Investigator award from the American Heart Association, and a Young Physician-Scientist award from the American Society of Clinical Investigation.
More recently, Dr. Rose has taken on leadership positions focusing on innovation, development, and entrepreneurship in academia. In 2020, he was appointed the Director of Innovation and Entrepreneurship in the Division of PACCM and the Vascular Medicine Institute, leading efforts to catalyze invention disclosures, counsel investigators through the commercialization process, and help develop innovation-based grants for investigators. During the COVID-19 pandemic, Dr. Rose has served as Interim Director of Alternative Resourcing, helping Department efforts to explore innovative solutions to potential shortfalls in PPE and medical devices. He is active as a member of the Drug/Device Discovery and Development Committee of the American Thoracic Society that fosters the bridge between leaders in respiratory therapeutics, academia, and the device industry.
In his new role within the Department of Medicine, Dr. Rose will partner with UPMC Enterprises and the University of Pittsburgh to enhance innovative research and the commercialization of projects within the Department. He will work with Divisional leaders and Department faculty to connect investigators with the UPMC Enterprises Translational Sciences Group and leverage their expertise and financial resources for commercialization of critical biomedical discoveries.
As a department, a key focus moving forward is expanding innovation and our broader impact on biomedical research and health care. The creation of a new leadership position around innovation and commercialization is a critical component to achieving these goals. We are fortunate to have a talented physician-scientist with Dr. Rose’s unique training, passion for innovation, and experience in commercialization to lead our Department in its entrepreneurial pursuits.